Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subspecialties Clinical care, Laboratory management, Microbiology and immunology

Industry Insights In…

At a Glance

  • High profile public health emergencies have raised awareness of the importance of infectious disease diagnostics, but huge unmet needs still exist, especially in low- and middle-income countries
  • Validation of diagnostics is also a big concern; many laboratory tests have not been adequately validated
  • It is difficult for lab professionals to decipher which tests have high-quality performance; medical education is needed to support effective decision-making
  • There are many exciting innovations in infectious disease testing, but a change in the approach to hospital financing is necessary for the field to progress and for patient care to be improved

If you scour decades’ worth of health stories in consumer literature, you’re likely to see a great number of articles on “groundbreaking” developments in the treatment of a given condition. Fast forward to the present day and, though these (often sensationalist) stories still abound, you are more likely than ever before to read about a new diagnostic test or screening program in your daily newspaper. Much of this attention has been driven by the molecular diagnostics revolution – particularly in oncology, but recent public health emergencies, such as Ebola and Zika, have also had an impact. And though increased awareness of the criticality of good diagnostics is great for the field, there are downsides. We spoke with Mark Miller, Chief Medical Officer of bioMérieux, to find out more...

Read the full article now

Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

Mark Miller

Mark Miller is the Chief Medical Officer of bioMérieux.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register